Ardelyx | ARDX - Gross Profit On Sales

Stock Price
5.41
Daily Change
-0.15 -2.61%
Monthly
-5.67%
Yearly
-1.55%
Q1 Forecast
5.61

Ardelyx reported $114.37M in Gross Profit on Sales for its fiscal quarter ending in December of 2025.





Gross Profit On Sales Change Date
Abbott USD 6.54B 625M Dec/2025
Amgen USD 6.48B 307M Sep/2025
Ardelyx USD 114.37M 8.02M Dec/2025
aTyr Pharma USD 190K 15.57M Sep/2025
Corcept Therapeutics USD 199.58M 3.46M Dec/2025
Curis USD -7.72M 140K Jun/2024
Sanofi EUR 8.45B 3.02B Dec/2025
TG Therapeutics USD 154.43M 20.81M Dec/2025
United Therapeutics USD 315.5M 286.6M Dec/2025
Xoma 992K 846K Jun/2024